1. Home
  2. Analysis
  3. Strattera
  4. Fluphenazine

Strattera and Fluphenazine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Strattera and Fluphenazine. Common interactions include chronic kidney disease among females and anxiety among males.

The phase IV clinical study analyzes what interactions people who take Strattera and Fluphenazine have. It is created by eHealthMe based on reports of 6 people who take Strattera and Fluphenazine from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Feb, 06, 2023

6 people who take Strattera and Fluphenazine together, and have interactions are studied.

What is Strattera?

Strattera has active ingredients of atomoxetine hydrochloride. It is often used in attention deficit hyperactivity disorder. eHealthMe is studying from 28,423 Strattera users for its effectiveness, alternative drugs and more.

What is Fluphenazine?

Fluphenazine has active ingredients of fluphenazine decanoate. It is often used in schizophrenia. eHealthMe is studying from 2,116 Fluphenazine users for its effectiveness, alternative drugs and more.

Number of Strattera and Fluphenazine reports submitted per year:

Strattera and Fluphenazine drug interactions.

Common Strattera and Fluphenazine drug interactions by gender *:

female:

  1. Chronic kidney disease
  2. Drug administration error
  3. Grunting
  4. Sinusitis
  5. Sleep apnoea syndrome
  6. Suicidal ideation
  7. Tic
  8. Weight increased

male:

  1. Anxiety
  2. Confusional state
  3. Visual impairment
  4. Decreased appetite
  5. Disorientation
  6. Dysstasia
  7. Emotional distress
  8. Hiccups
  9. Mood swings
  10. Stress

Common Strattera and Fluphenazine drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Hiccups
  2. Mood swings
  3. Stress
  4. Suicidal ideation
  5. Visual impairment
  6. Drug administration error
  7. Grunting
  8. Tic
  9. Weight increased
  10. Anxiety

20-29:

n/a

30-39:

  1. Sinusitis
  2. Sleep apnoea syndrome
  3. Suicidal ideation

40-49:

  1. Chronic kidney disease

50-59:

n/a

60+:

n/a

* Approximation only. Some reports may have incomplete information.

Do you take Strattera and Fluphenazine?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Strattera and Fluphenazine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Strattera side effects:

Browse all side effects of Strattera:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Fluphenazine side effects:

Browse all side effects of Fluphenazine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Strattera interactions:

Browse all interactions between Strattera and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Fluphenazine interactions:

Browse all interactions between Fluphenazine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on atomoxetine hydrochloride and fluphenazine decanoate (the active ingredients of Strattera and Fluphenazine, respectively), and Strattera and Fluphenazine (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Strattera and Fluphenazine.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2023 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.